Abstract
Kimberly-Clark will release first-quarter 2026 results on April 28, 2026 Pre-Market, with current projections pointing to approximately 4.09 billion US dollars of revenue and 1.89 adjusted EPS while investors monitor EBIT trajectory, pricing elasticity, input-cost volatility, and updates surrounding the pending Kenvue transaction.Market Forecast
For the current quarter, projections indicate revenue of 4.09 billion US dollars, representing a 16.26% year-over-year decline, and adjusted EPS of 1.89, implying a 0.27% year-over-year increase; EBIT is projected around 0.68 billion US dollars, down 19.44% year over year. Forecasts for gross profit margin and net margin have not been disclosed alongside these estimates.Within the company’s revenue mix, Baby and Child Care remains the largest contributor, and management focus this quarter is on protecting price-pack architecture and stabilizing volumes as promotions normalize and elasticity remains contained. The most promising profit lever in the near term appears to be the Family Care franchise given its historically attractive mix and margin sensitivity to input-cost movements; revenue within Family Care stands at 4.06 billion US dollars, and against a company-level year-over-year revenue decline of 17.21% last quarter, its ability to leverage pricing and productivity will be a key support.
Last Quarter Review
In the prior quarter, Kimberly-Clark reported revenue of 4.08 billion US dollars (down 17.21% year over year), a gross profit margin of 36.99%, GAAP net profit attributable to shareholders of 499.00 million US dollars, a net profit margin of 12.23%, and adjusted EPS of 1.86 (up 24.00% year over year). Adjusted EPS exceeded the prior consensus estimate by approximately 0.05, while revenue was roughly 0.01 billion US dollars below expectations. In the reported business mix, Baby and Child Care led with 6.77 billion US dollars in revenue, followed by Family Care at 4.06 billion US dollars, Adult Care at 1.95 billion US dollars, Professional at 1.84 billion US dollars, Feminine Care at 1.71 billion US dollars, and All Other at 124.00 million US dollars; year-over-year growth by segment was not disclosed in the breakdown.Current Quarter Outlook
Baby and Child Care: price architecture, elasticity, and category investment
Baby and Child Care is the company’s anchor category and a primary determinant of quarterly earnings cadence due to its scale and brand breadth. With the consensus pointing to a 16.26% decline in total revenue and a 19.44% decline in EBIT, the pathway to stability this quarter revolves around sustaining premium price points where brand equity is strongest while testing targeted promotions in value tiers to protect share without destabilizing margins. The early-2026 environment has featured an uptick in promotional intensity across staples names, but last quarter’s 36.99% gross margin and 12.23% net margin suggest the company exited 2025 with adequate headroom to use mix and productivity to counterbalance elasticity. Management attention to size/pack architecture and retail execution is likely to prioritize repeat rates and shelf presence over deeper price-driven share wins; this tends to support EPS durability, which is reflected in the near-flat forecast trajectory for adjusted EPS (up 0.27% year over year). FX remains a watch point for this franchise due to exposure to multiple currencies, but the negative translation that weighed on reported top line in 2025 could moderate if the dollar stabilizes; any relief here will help flow-through in Baby and Child Care’s contribution. On balance, investors should expect Baby and Child Care to remain a stabilizer of gross profit given brand-led pricing power and cost productivity, even as volume rebuilds proceed gradually.Family Care: margin mix, input-cost sensitivity, and price-pack strategy
Family Care (tissue and towel) is a margin-sensitive business that can benefit disproportionately when input costs trend favorably and when pricing sticks, and it remains central to near-term EBIT outcomes. The forecast EBIT contraction of 19.44% year over year for the quarter implies that the company will need to offset both weaker reported revenue and a less favorable overhead absorption environment; Family Care’s flexibility on product mix and price tiers can help narrow that gap. External commentary in early April flagged resin and oil-linked inputs as a renewed risk across household and personal care categories; for Kimberly-Clark the more direct commodity lever is pulp, but resin-linked packaging and freight can also pressure conversion costs. The company’s productivity and savings programs provide a buffer, and last quarter’s 36.99% gross margin demonstrates progress exiting 2025, which can soften the impact of near-term input inflation if it proves transitory. Promotional dynamics in paper categories can be choppy; the key this quarter is to calibrate discount depth so as not to impair the net price realization progress built over the last two years, while sustaining shelf availability. Net-net, Family Care can still function as a gross-margin lever if commodity headwinds are contained and mix management remains disciplined, supporting the consensus view for stable adjusted EPS despite softer revenue.Key swing factors for share performance this quarter
The most immediate swing factor is input-cost volatility tied to commodities and packaging, which can influence both gross margin and the cadence of promotional spend; early-April research highlighted the risk of sticky resin costs due to geopolitical developments, increasing the need for agile pricing and productivity. A second factor is execution around the Kenvue transaction pathway: shareholders of both companies approved the deal in late January, and the company outlined a future operating structure in mid-April; while closing is targeted for the second half of 2026, incremental disclosures on financing, expected cost synergies, and migration milestones can shape sentiment toward the quarterly run-rate and forward multiple. Third, operational continuity and customer service metrics are in focus following the early-April fire at a third-party-operated California distribution center; while management indicated insurance coverage for business interruption and no impact to manufacturing assets, investors will watch for any temporary shipment friction or incremental logistics costs in the quarter. Also relevant are FX translation and the timing of productivity benefits; stabilization in the dollar would ease comparisons for international businesses, while phasing of savings programs could support EBIT if commodity pressure persists. Lastly, guidance cadence matters: with consensus modeling a 0.27% year-over-year uptick in adjusted EPS against a 16.26% revenue decline, investors will be particularly sensitive to commentary on gross-to-net pricing, elasticity, and whether management reiterates or updates full-year trajectories pending the Kenvue close.Analyst Opinions
Across notes published between January 1, 2026 and April 21, 2026, the balance of opinions skews neutral, with Hold, Neutral, or Equal Weight ratings dominating recent updates and target-price adjustments; this is the majority stance relative to Buy/Overweight calls. UBS on April 7, 2026 maintained a Neutral rating with a 105 US dollars price target, signaling that the stock’s risk-reward is balanced in the near term given mixed top-line momentum and input-cost uncertainty. Deutsche Bank on April 13, 2026 reiterated a Hold rating and modestly adjusted its target to 108 US dollars, reflecting expectations for flattish adjusted EPS on the back of disciplined pricing offset by volume softness and higher conversion costs. Wells Fargo on February 17, 2026 kept an Equal Weight rating and nudged its price target to 110 US dollars, emphasizing that valuation appropriately discounts near-term variability in revenue as the company preserves margins through savings and mix. Barclays on January 20, 2026 maintained an Equal Weight/Hold stance with a 102 US dollars target, consistent with a view that quarterly revenue pressure tempers upside despite a constructive longer-term savings framework. Evercore ISI on January 13, 2026 reiterated an In-Line/Hold rating with a 120 US dollars target, citing a wait-and-see approach ahead of clearer proof points on volume reacceleration and the sequencing of integration milestones. TD Cowen in early April kept a Hold rating with a 96 US dollars price target while flagging the sector’s resin-cost risks; although resin is a packaging and logistics input rather than a primary fiber input, the broader cost stack could still experience short-term pressure.The majority-neutral view converges on a common set of near-term themes: adjusted EPS should hold up better than revenue due to pricing discipline, productivity actions, and mix management, but volume elasticity and commodity noise constrain conviction on upside until more consistent top-line growth emerges. Analysts in this camp generally see scope for a better second half as savings accumulate and pricing roll-offs annualize, while acknowledging that the timing and mechanics of the Kenvue combination add moving parts to forecasts. Against the current-quarter setup—revenue estimated at 4.09 billion US dollars (down 16.26% year over year), EBIT at 0.68 billion US dollars (down 19.44% year over year), and adjusted EPS near 1.89 (up 0.27% year over year)—neutral-rated institutions expect management to prioritize margin resilience and cash generation, with any incremental commentary on supply chain normalization and integration planning serving as catalysts for sentiment recalibration. This consensus implies that positive share reaction likely requires either evidence of faster volume recovery in core categories or clarity on synergy timing and capital deployment associated with the pending acquisition, whereas a negative reaction could stem from signs of input-cost stickiness or atypical promotion depth that dents gross-to-net capture. Overall, the center of gravity in recent institutional commentary remains cautious-to-neutral for this print, prioritizing proof of revenue stabilization over multiple expansion near term while acknowledging the potential for medium-term reshaping once the Kenvue transaction closes.
Comments